procarbazine has been researched along with Theca Cell Tumor in 1 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vinokurov, VL | 1 |
| Vinokurova, NA | 1 |
1 trial available for procarbazine and Theca Cell Tumor
| Article | Year |
|---|---|
[Therapeutic effect of natulan in a recurrence of a granulosa theca cell tumor of the ovaries (1 case)].
Topics: Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Middle Aged; N | 1979 |